The EU AI Act: Steps to Take in the First 6 Months
6 minute read | April.01.2024
This update shares six steps organizations should consider taking now to kick off their AI Act compliance obligations.
The EU AI Act Essentials Series: Key Takeaways for Companies Using and Developing AI
The European Union’s Artificial Intelligence Act (AI Act) has been adopted and will be taking effect this year, with the bulk of its provisions being enforceable after two years, subject to some notable exceptions.
Our EU AI Act Essentials Series provides key information for affected companies, including recommendations to kick off a compliance plan. This Series will be updated as developments occur.
The EU AI Act: Who Is Covered?
5 minute read | April.09.2024
The AI Act covers a wide range of actors in the AI value chain, namely in the development, use and commercialization of AI systems and general-purpose AI models. This update covers the broad material and territorial scope of application and details the main categories of actors that are impacted.
The EU AI Act: New Investigative Powers for the European Commission – What AI Providers Should Know
6 minute read | April.15.2024
The AI Act grants the European Commission new investigative and enforcement powers over providers of some AI technologies, including general-purpose AI models such as generative AI products. This update covers investigative powers and explores who is impacted, lessons from the antitrust realm and measures companies can consider to mitigate risk.
The EU AI Act: Key Takeaways for Life Sciences and Digital Health Companies
5 minute read | May.20.2024
This update provides an overview of the AI Act’s applicability to use cases in the life sciences and health tech spaces. It also addresses key considerations for companies deploying or leveraging AI/ML tools in these industries.
The EU AI Act: Open-Source Exceptions and Considerations for Your AI Strategy
6 minute read | May.20.2024
This update provides an overview of the AI Act’s applicability to use cases in the life sciences and health tech spaces. It also addresses key considerations for companies deploying or leveraging AI/ML tools in these industries.
If you have questions about the EU AI Act, please reach out to Julia Apostle or another member of our Artificial Intelligence & Machine Learning practice.
Insights
Utah AI Laws Require Consumer-Facing Disclosures Starting May 1
by Shannon Yavorsky, Nicholas Farnsworth and Peter Graham
5 minute read | April.22.2024
Two laws take effect in Utah on May 1 that impose legal requirements on a broad range of generative AI uses.
Massachusetts Attorney General Shares Artificial Intelligence Guidance: What Businesses Need to Know
by Andrew Cook, Rob McKenna, Brian T. Moran and Adam Braun
5 minute read | April.19.2024
While Congress and states slowly enact AI regulations, state attorneys general already have broad statutory authority to enforce AI.
Transactions in the Age of Artificial Intelligence: 5 Potential Pitfalls to Consider
by Heather Egan, Daniel Forester, Richard F. Martinelli and Daniel Patrick Kearney
4 minute read | August.03.2023
Rapid growth in AI has made it a major focus of technology transactions. We've identified five potential risks that support a tailored approach.
Generative AI Growth Demands New and Updated Company Policies. The Gen AI Policy Builder Can Help
by Annette Hurst, Shannon Yavorsky and Daniel Healow
5 minute read | January.25.2024
The new Gen AI Policy Builder makes it easy for a company to create a comprehensive internal policy to govern current and future use of Gen AI tools.
8 Intellectual Property and Commercial Questions to Ask Your Generative AI Tool Provider
by Annette Hurst, Daniel Yost, Ramin Tohidi, Sarah Schaedler and Daniel Healow
10 minute read | August.03.2023
As AI products surge, companies must balance tech capabilities, legal/financial concerns. Providers push limits, address ethics, and user guardrails.